Table Of Content

Kidney International, Vol. 58 (2000), pp. 2624-2633 Key Word Index For Volume 58 A Angiotensin converting enzyme inhibitors .......... 2111 Access recirculation Angiotensin II 242, 575, 2320, 2437 ACE inhibition 1664, 2093 Angiotensin II type 1 receptor ACE inhibitors 903, 2265, 2485 Angiotensin receptor antagonist ................. 2485 al Acid glycoprotein 346 Angiotensin-converting enzyme gene polymorphism Acid-base balance 748, 1765, 2069 Angiotensinogen Acidity Animal model of IgAN Acquired cytoresistance Animal models Acridine orange Anovoluatory cycles Activator protein-1 Anticancer drug Acute glomerulonephritis Antidiuretic hormone Acute graft rejection Antifibrosis factor Acute nephritis Antihypertensive therapy Acute rejection Anti-MHC class I antibody Pane SHAE TRINNMNDS 5 625.9! at'sl os aise po) S464, 6 bis 390, 658, 829, Anti-obesity hormone 889, 1121, 1751, 2237, 76:S-96, 76:S-156 Antioxidant Acute tubular necrosis 283, 1580 Antioxidant therapy Adenine phosphoribosyltransferase deficiency Anti-oxidants 1780, 2186 Adenosine triphosphate Aorta 153, 2425 Adenosine 5’-triphosphate Apical membrane domain Adequate dialysis 336, 800, 2512 11, 82, 123, 607, Adhesion 1148, 1186, 1941, 1996, 2235, 2331, 2546 PPA AINMIBCUIOS 665.s a5cy s5s st6e s eas 1121, 2166 ApoTACS assay Adipose tissue Arachidonic acid Adolescent renal failure Arginine ADPKD L-arginine Advanced glycation Arginine vasopressin Advanced glycation end products Arterial blood pressure Adynamic bone disease 753 Arterial disease 76:S-140 Afferent arteriolar hyalinosis .................... 1174 Arterial hypertension 770, 2408, 2462 Afferent arteriole 1686, 2053 Arteriovenous graft Arthropathy Age and hip fracture Artificial viral envelope AGE-receptor Ascorbic acid PeM CCA MIOL 5, 2 5 <iis:'s a 6 as dg SSB SS eS 2018 Atherogenic dyslipidemia Atherosclerosis ....................549, 867, 76:S-120 Albumin binding proteins Atherosclerotic cardiovascular disease Albumin-to-creatinine ratio Atrial natriuretic peptide Albuminuria 2) a A, PRUNES TACO oo ia saccaea sednsese e ee Autacoid Autoantibody production Aldose reductase Autocrine-paracrine factor Alkali feeding Allograft dysfunction Autoradiography Allograft rejection Autosomal dominant polycystic kidney disease Autosomal recessive inheritance Alport syndrome Amenorrhea Azotemia Amino acid peptide Azurophilic granules Amino acids oO ener 2525 B Amyloidosis 76:S-120 Bacteremia AN69 Bacteria Bardet-Biedl syndrome Analgesic-associated nephropathy POONA CEN GATOMIOMNAR ... os co ce cee cscwaceeses 2186 ANCA Basement membrane 115, 1719, 2206 Anemia 467, 2007 RNR 85 6:s hon ce 6 sek Sia.sois gawd ache dckiaens eee 2178 Berger’s disease 966 PENN 56.5 56,5: 6s. div Harel a gle Se 647, 2390, 77:S-113 DIT ne te oo as gens: wus «aps a Sie eS 2119 Angiopoietin Bicarbonate flux Angiotensin 1219, 77:S-93 2624 Kidney International, Vol. 58 (2000), pp. 2624-2633 Key Word Index For Volume 58 A Angiotensin converting enzyme inhibitors .......... 2111 Access recirculation Angiotensin II 242, 575, 2320, 2437 ACE inhibition 1664, 2093 Angiotensin II type 1 receptor ACE inhibitors 903, 2265, 2485 Angiotensin receptor antagonist ................. 2485 al Acid glycoprotein 346 Angiotensin-converting enzyme gene polymorphism Acid-base balance 748, 1765, 2069 Angiotensinogen Acidity Animal model of IgAN Acquired cytoresistance Animal models Acridine orange Anovoluatory cycles Activator protein-1 Anticancer drug Acute glomerulonephritis Antidiuretic hormone Acute graft rejection Antifibrosis factor Acute nephritis Antihypertensive therapy Acute rejection Anti-MHC class I antibody Pane SHAE TRINNMNDS 5 625.9! at'sl os aise po) S464, 6 bis 390, 658, 829, Anti-obesity hormone 889, 1121, 1751, 2237, 76:S-96, 76:S-156 Antioxidant Acute tubular necrosis 283, 1580 Antioxidant therapy Adenine phosphoribosyltransferase deficiency Anti-oxidants 1780, 2186 Adenosine triphosphate Aorta 153, 2425 Adenosine 5’-triphosphate Apical membrane domain Adequate dialysis 336, 800, 2512 11, 82, 123, 607, Adhesion 1148, 1186, 1941, 1996, 2235, 2331, 2546 PPA AINMIBCUIOS 665.s a5cy s5s st6e s eas 1121, 2166 ApoTACS assay Adipose tissue Arachidonic acid Adolescent renal failure Arginine ADPKD L-arginine Advanced glycation Arginine vasopressin Advanced glycation end products Arterial blood pressure Adynamic bone disease 753 Arterial disease 76:S-140 Afferent arteriolar hyalinosis .................... 1174 Arterial hypertension 770, 2408, 2462 Afferent arteriole 1686, 2053 Arteriovenous graft Arthropathy Age and hip fracture Artificial viral envelope AGE-receptor Ascorbic acid PeM CCA MIOL 5, 2 5 <iis:'s a 6 as dg SSB SS eS 2018 Atherogenic dyslipidemia Atherosclerosis ....................549, 867, 76:S-120 Albumin binding proteins Atherosclerotic cardiovascular disease Albumin-to-creatinine ratio Atrial natriuretic peptide Albuminuria 2) a A, PRUNES TACO oo ia saccaea sednsese e ee Autacoid Autoantibody production Aldose reductase Autocrine-paracrine factor Alkali feeding Allograft dysfunction Autoradiography Allograft rejection Autosomal dominant polycystic kidney disease Autosomal recessive inheritance Alport syndrome Amenorrhea Azotemia Amino acid peptide Azurophilic granules Amino acids oO ener 2525 B Amyloidosis 76:S-120 Bacteremia AN69 Bacteria Bardet-Biedl syndrome Analgesic-associated nephropathy POONA CEN GATOMIOMNAR ... os co ce cee cscwaceeses 2186 ANCA Basement membrane 115, 1719, 2206 Anemia 467, 2007 RNR 85 6:s hon ce 6 sek Sia.sois gawd ache dckiaens eee 2178 Berger’s disease 966 PENN 56.5 56,5: 6s. div Harel a gle Se 647, 2390, 77:S-113 DIT ne te oo as gens: wus «aps a Sie eS 2119 Angiopoietin Bicarbonate flux Angiotensin 1219, 77:S-93 2624 Key Word Index: Volume 58 Biocompatibility 417, 809, 818, 2044, 2518, 2571 Cell elasticity 76:S-60, 76:S-66, 76:S-104, 76:S-112 Cell growth Biocompatible membranes ..... 2.2.2ec.co6 c e 790 Cell hypertrophy Bioelectrical impedance analysis Cell injury Bioethics Cell proliferation .......... el eel 9s Ae Bio-incompatibility Cell regulation Biopsy Cell signaling Biopsy index Cell stress response Blood flow redistribution Cell volume Blood lactate Cell volume regulation 251, 260, 353, 721, 730, 989, Ce TM AMNE RG RAEMOIB s/f 5's.¢ .«'s:% ace eo8dions ied widen aloes , 1261, 1356, 1677, 2075, 2265 Cell-mediated renal injury Eslood) pressure COMIFO! . wece e ened 375, 460 Cellular crescents BIQOG@UECADIIOCEH 2... ok ce ie ede bere eee ELS Cellular dysfunction SOO CACC aeay ae ee ey 1557 Cellular immunity Blood volume 800, 76:S-79 CE hac dys kv oa oie eae d Wu eee 2400 Body fluid toxicity Central venous catheter Body water COMM are he ae ie afenacnl a «9's Sw @ wie.d.«, aa ee ee 2069 Bone CGF421128 peptide ligand . .... 2 ons «6 essa oe ins 2A Bone SU5 Sr. 76:S-60 Bone fracture and dialysis Chemokines , 1816, 2408 Bone growth Childhood diabetes 302 Bone metabolism CRANE ORME UNARNSIS So ok 5 ob aes esse Oda eee 2564 Bone mineral density SIONO CA TED 5) | Si a a a nr serene0 2492 Bone morphogenetic protein Cholecystokinin 995 Bone remodeling Cholesterol 293 Bosentan Chondroitin sulfate proteoglycan Chromosome 3 38 Chronic glomerular disease 1500 C Chronic giomerulonephritis . 1841 Chronic Hemodialysis; < :... 66. ke 790, 800, Cadaveric renal transplantation Chronic hemodynamic stress Calcineurin inhibition Chronic inflammatory disease WalClPOMIC HORMONES... ce ak ce be vine Ber es CHrGiie Pertoneds GIALVSIS. 25. 2% ce ce beeen 384 Calcium Chronic renal disease 51, 293, 436, 460, 2512 Calcium absorption Chronic renal failure ... 62, 173, 753, 981, 1023, 1202, 1267, Calcium oxylate monohydrate crystals 1732, 1758, 1780, 1805, 1980, 2007, 2178, 2228, 2564, 76:S-66 Calcium-PTH curve Chronic renal injury 144 Calcium-sensing receptor 1980 Chronic renal insufficiency , 2492 Calveolae 193 Chronic uremia 260 Candidate gene Chronicity Index 1160 O71 Da é Cigarettes and renal function 1285 Capillary hypertension Cisplatin 1450 Captopril 1 ee nS areRnraome Puro ty ce 206, 2102 a RMD a wg 0) dh Sasa did oF Ake x areata omens Maes EN Citric acid 1859 Carbonyl stress e- Tata) N-feniInA N REMASE:. 6s. ie ee os see ed 7, 1078 Cardiac disease Classification of lupus 1354 Cardiovascular CIASAARGHTE CADE MNES so: Ss 5c. bcs eas 2 ws Gs ae Ae 1742 Cardiovascular disease Clearance 238, 1318 Cardiovascular function 730 Clusterin 467 Cardiovascular MOrtalty ...6. 6s cee ce cee 260, 774 Collagen 14, 2351, 2425 Cardiovascular system 989 Collagen matrix 1088 Caspase 467 Collecting duct 701 Catabolism 336 Combined analgesics Cation transporter 944 Complement C3 and C5b-9 CD4 Compound heterozygosity CD8° cells Computerized gene simulation CD28 knockout mice Concentration polarization Cell adhesion 1420, 77:S-31 Congenital obstructive nephropathy 1987 Cell cycle 674, 2044, 2377 Congenital renal parenchymal defects 500 Cell cycle regulation Congenital tubular disorders Cell cycle-dependent hypertrophy 162 Congenital ureteropelvic junction obstruction Cell death’... <..... 269, 1078, 1481, 1876, 1920, 2301, 77:S-67 Continuous renal replacement therapy Cell development Convoluted tubule epithelium 1902 Cell differentiation Coronary risk factors 353 2626 Key Word Index: Volume 58 Cortical cell turnover DIGtARy PYOIEMD oc. 5 cic es ce eke eee coe SOON OME Corticosteroid toxicity Diffusive solute clearance REVO IIE 55 iw sc ec ces ee 346, 1703, 76:S-96 PRUNE UVIMORUING 6.9 c igo sieie ge ieisrs scales Silda qherees 2075 Creatinine clearance Direct son-selective electrode... 26 ck cece 2194 Crescentic glomerulonephritis 1816, 1941 DNA strand breakage Critical care Dopaminergic system Cross-linked fibrin Dose of prednisolone Crystalluria Drug interaction Cuprophan membranes Dry body weight Cyclic GMP Duffy antigen receptor for chemokines Cyclic mechanical strain Dynamic capillaroscopy Cyclic stretch Dyslipidemia Cyclin-dependent kinase inhibitor Cyclosporine E Cystic renal dysplasia Cystinosis Early nephropathy Cystogenesis Ecarin clotting time Cytokine Gemma And Fast GIBIYSIS ooo ii. ee Se le cee 1202 Cytokine gene polymorphism 783 Eicosanoids Cytokines 43, 467, 76:S-104, 76:S-148, 77:S-104 Eicosatrienoic acid REPN RMNRMOEINID 555.5 aka s3 vbw s 5g aoe ola g eS Ores SRN 2400 Electrolyte balance SEMEN ROTIOEL, 5555.55. oi-ave due ard aidd a 646 D'S bien Ge ne Electrolyte transport Cytotoxicity Embryonic metanephros Enalapril D RSPEI S22 ere 5-5, w.w desa. acw ise 5,'e Ud Iola segue 1529; ERRNO RAD oo So shaw Kali cena e Saee eee ase 2007 PSGORA N GOATAARO oo. 505 5 si vs da cies bu a dle US Crone DARC 1816 Endothelial cells SPUNMORUIANOEGBA . oi6 .5 ooo ow 0 cles ces waiswis 6 ee eee Endothelial DARC expression Delayed graft function 838 Endothelial injury RBOMOMR MUON oso. o 6S5 5)5 ide ayn laiciincy iw « clal o nites SOE Endothelin Desferrioxamine 658 ESN UNIAE 52 bae'e-8 c)o s 59-)0'4 Scans nemaneecaiohaiaeehale 2075, 2166, 2390 SE CREED es 5 de. Wile ocd oso 0)'a'o. ela tare wallow 2400 Endotoxin Deuterium oxide End-stage renal disease . . . 115, 317, 375, 384, 400, 436, 491, Development 513, 851, 873, 1211, 1253, 1293, 1311, Dexamethasone 1325, 1356, 1381, 1695, 1703, 1805, 1810, Lo Sa eae ea 2084, 2178, 2452, 77:S-67, 77:S-93 1820, 2221, 2228, 2235, 2478, 76:S-28, 76:S-89, 76:S-156 Diabetes mellitus ......... 1492, 77:S-3, 77:S-26, 77:S-104 End-stage renal failure .... 302, 2093, 2259, 2408, 76:S-126 PIADCUC COMPHCANONS ...... 5.55c.s 2cw es 1931, 77:S-31 Envelope protein Diabetic nephropathy ......... 229, 959, 1389, 1841, 1963, Epidemiology 2320, 77:S-59, 77:S-67, 77:S-81 Epiphyseal growth plate Diabetic vascular complications ............... 77:8-113 PSP UIIPC RIA MICRITIN ©5 .5. 2056: S.50504: 90514, o'-<isne alo rw leyameobere 1963 Diagnosing hypertension Epithelia 11 Diagnostic tool TCTeer Tere ree tT 2028 Dialysate 1751, 76:S-66, 76:S-72, 76:S-79, 76:S-89 Epithelial injury EEO MMCMEUIES 5.6, 5.w ide nee Nee at eis ee See 2194 Epoetin a Dialysis 1, 353, 396, 818, 867, 1253, 1311, 1805, Equilibrated Kt/V 2200, 2543, 76:S-96 ERK1/ERK2 Dialysis adequacy 1318, 2155, 76:S-3, 76:S-19, Erythropoietin 76:S-28, 76:S-41, 76:S-156 E-selectin Dialysis capacity Essential hypertension Dialysis cost Dialysis disequilibrium syndrome Essential trace element Estrogen replacement Dialysis dose Dialysis efficiency Estrous cycle Dialysis machine Excretion Dialysis mortality 2147, 76:S-140 Excretion of NOx Dialyzer 809 Exit-site infection EE 2119 Exon skipping 1870 Dialyzer membranes 790 PRPCHIBACORNIGGENS «oo. 5.6 seein esis 5 otis uw eaiew ane 1461 Diastolic blood pressure Extracellular matrix 251, 537, 1108, 1174, Diastolic pressure 1389, 1534, 1588, 1841, 1953, 2331, 77:S-19, 77:S-76 Diet Extracellular matrix protein Diet and dialysis Extracellular matrix turnover Dietary metabolic needs Extracellular signal-regulated kinase ............... 27 Dietary phosphate Extracellular-regulated kinase Key Word Index: Volume 58 2627 F Glomerular cytoskeleton ..... 2... cece cece Oe Fabry disease Glomerular disease 966 F-actin microfilaments Glomerular epithelial cells... . 0..cc.c a ces 1342 Factor-B Glomerular filtration barrier Familial hypercalciuria Glomerular filtration rate . 1336, 1686, 2075, 2093, 2367 Fas Glomerular gene transfer 467 Glomerular hemodynamics ..................... 2331 MEN RUM RNTCRNN So oo2 055 0.A vie,S o Sud SSeS we eee eRe 408 Sf PTCTET eeeT Te e RicRRUME MITEL a 7555. day crear aco. oadene Sie’ cca sretauanase Goer 1695 Glomerular lesion Femoral catheter Glomerular morphometry Fetal antigens Glomerular permeability Fetal renal function 312 Glomerular podocytes PNNOPR E E RED hie 25 Soc ed lan ds Sue wea hah reel ea ae ALES 587, 1885 Glomerular sclerosis Fibronectin Glomeruli PINON hogs Asso) aia es ae ea ess 51, 618, 838, 1174, 1186, 90, 115, 598, 783, 1219, 1641, 2301, 2351, 2425, 77:S-59 1108, 1461, 1603, 1920, 2377 Fibrotic kidney disease 1557 Glomerulopathy 2129 Glomerulosclerosis 691, 1067, 1088, Filter rinsing solutions 881 1135, 1664, 1797, 1885, 77:S-67 Filtration barrier 1973 Glomerulus PHmation Battier defect 2... 2. sc dade sees cee wee 2129 Glucose 1534, 1751, 77:S-93 Filtration dynamics 1228 CINMEOEE CONCEHITANON So. 5.5 .d6 ace a4 0 os. cen noes Lee 2194 Finnish acute renal failure 1711 Glucose degradation product Finnish-type nephrotic syndrome 925 Glutamine : fructose-6-phosphate-amidotransferase . 77:S-13 IN eo Seis hie ee Was sie nak oe 2194 Glycated albumin 684 Fluid balance 809, 1765 Glycation Fluid exchange 1773, 76:S-79 Glycemia Pith esehatce DARIO! oc. ce cee awe ec enaes 2061 Glycoprotein RpRerR MSE SURGING eo ssis os 5 ao Wace, 6-508 oF mF slavelelarm ne WaleS 2492 Glycoprotein receptor Fluid volume Glycoxidation 1931 Focal segmental glomerulosclerosis 1148, 1342, 1732, 1841 gp120 1148 Folate CIN aMM RIN ao 55 bine nb Bae elo 'ea A a ee 2166 Fourier transform infrared analysis Graft function Free radical metabolism Graft rejection Free radicals Graft survival Frequent relapse of nephrotic syndrome Granulomatous lesions Growth Growth factors G Growth hormone G protein Growth of bone G protein-coupled receptors Growth retardation Gastrin GTP-binding proteins Gastrointestinal hormone receptors Guanylyl cyclase Gastrostomy Gubbio Population Study MPrerMPPEHEIANOE RE oo oo, ojn -9'0 0 wlan evn cia soars a & Slo deere alele 2377 SELLE tSI R te pe a PC ea rte Per de 2178 H Gender and ESRD IDRSRRNDRS SEMEN ON 2) C215. oso havea Kiohe pia eran Wiele ee 1859 Gene conversion HAS gene expression Gene expression Gene knockout mice Hearing loss Gene mutation Heart Gene polymorphism Heart failure 1751, 76:S-140 Gene regulation Heart fibrosis 537 Gene therapy Heart transplant 325 Gene transfer Heat shock protein 47 587 Genetic epidemiology DD RRRpNRMNMER D os Sods Bro o wits a: ee wrel ee are-a ela eee eee 2119 Genetic etiology Hematuria MFEMEPIE SUSCOPEIOIEEY: 5.6 5 osc ck ois ae ole Hele eels Be eo we 2 Hemizygosity Genetics Hemodiafiltration Genital anomalies Hemodialysis ..... 417, 436, 446, 629, 873, 881, 1293, 1381, Genotype-phenotype correlation 1695, 1758, 1810, 2138, 2571, 76:S-47, 76:S-79, Glomerular albumin permeability 76:S-112, 76:S-120, 76:S-156 Glomerular basement membrane Hemodialysis complications Glomerular capillary tuft Hemodynamics 144, 242, 460, 730, 989, 1641 Glomerular cells Hemofiltration 2628 Key Word Index: Volume 58 Hemoglobin Immunocytochemistry ES a Hemolytic uremic syndrome Immunofluorescence Hemolytic-uremic syndrome Immunoglobulinuria ...................020000. 2129 Hemoperfusion Immunohistochemistry Hemorrhagic fever Immunomodulation Heparin Immunosuppression SET; S25, 1652 Hepatic cirrhosis Inducible nitric oxide synthase 1420, 1641 Hepatic production Infant renal failure Hepatorenal syndrome Infant urine Hereditary disease Infection , 1920, 2543 RETO, ooo 6 ssh os sw 4 os oe ne 5 DIG BIOS IO ee Infection risk 790 EARDMMIK MOIMOGIAIVSIS 5.5.5 one's. ono oo Soe wee es oles 809 Inflammation ... 43, 100, 115, 346, 417, 684, 783, 867, 1055, High glucose 1108, 1160, 1354, 1603, 1641, 1797, 2166, eye High turnover bone disease Inflammatory cascade Inflammatory cytokines HIV-associated nephropathy Inflammatory glomerular disease HMG CoA reductase inhibitor Inflammatory response ........... 598, 76:S-96, 76: ~ 126 Homeostasis Infusion Homocysteine Injury Hospital reimbursement Injury pathways Human reproduction Insulin Human umbilical vein endothelial cells Insulin secretion HVJ liposome Insulin-dependent diabetes .................. 302, 959 Hyaline lesions Insulin-like growth factor-I 62 Hyaluronan Intensive care 76:S-140 Hydrochlorothiazide Intensive care medicine : Hydronephrosis Interferon-y 559 Hydrosodium removal INLCHAMELENE GIAIVSIS 3. 5 56 os is ee cc we ote we 76:S-3 Hydrostatic pressure Intermittent hemodialysis ...................... 2579 8-Hydroxyguanine Interstitial cell apoptosis Hypercalcemia 71, 981, 1016 Interstitial cells Hypercalciuria 1267, 1278 Interstitial fibrosis Hypercholesterolemia Interstitial inflammation Hypercitrituria Interstitial lesions Hyperfiltration Interstitium Hyperfiltration nephropathy Intracellular free calcium concentration Hyperglycemia 684, 1360, 1389, Intracellular pH 1534, 1677, 77:S-13, 77:S-26, 77:S-40 Intracellular signaling Hyperhomocysteinemia Intracellular tonicity Hyperkalemia Intracorporeal urea mass transfer coefficient Hyperosmosis Inttacramial aneurysms... .... 2... 6. e ss eee es eee 2599 Hyperphosphatemia Intrauterine growth Hyperplasia Inulin Hypersensitivity reactions 881 Inulin clearance Hypertension . . 153, 229, 458, 549, 721, 762, 889, 1261, 1356, lohexol 1413, 1719 Ionic dialysance Hypertensive nephrosclerosis ...................- 2235 IRMA for PTH Hypertrophy 62, 1088, 2044, 77:S-59 Iron chelators Hypoproteinemia 972 Ischemia 58, 691, 838, 2367, 2390 Hypotension 1805, 2147 Ischemia-reperfusion injury 359, 1902 Hypoxia 82, 1912, 2367 Ischemia-reperfusion syndrome Ischemic heart disease Isoforms of PKC Isoprenoids Idiopathic membranous glomerulonephritis J Idiopathic nephrotic syndrome Japanese dialysis IgA nephropathy MPA Rena OU Oo 5-5,f oo ns in“ aig oda oha rderarw atal tetelare eters 2543 IgG subclass deficiency Jun N-terminal kinase Iliac cortices Nils atts ae ps Xoo 4 awn 1300 K Immune complex glomerulonephritis .............. 2215 OOS ee Rae ERR RTT rts cee ee 2400 Immune deficiency syndrome 607 Immune response 1546, 1941 Ki-67 cell type specific markers Immune system and pregnancy Kidney . . 27, 674, 721, 1492, 1511, 1613, 1632, 1686, 77:S- 45 Key Word Index: Volume 58 Kidney and HIV Kidney aorta Magnesium deficiency Kidney cells Maintenance dialysis Kidney cysts Major histocompatibility complex Kidney development Malnutrition Kidney dialysis Manganese Kidney disease 1931, 2084 MAP kinase Kidney donor 2314 MAPK Kidney failure 1261, 1440, 2478 NMistermal ames Tespomee «.. .. 6. ccc cnae 2240 Kidney fibrosis ES Pissae$ l Sign dhs Sisp horcgr Gosek ania GOR OTA 2367 Math modeling Kidney function Mathematical modeling Kidney graft function Kidney graft rejection Matrix degradation Kidney injury Matrix metalloproteinases ........... 2028, 2351, 77:S-81 Kidney lesions Matrix turnover Kidney malformation MDCK Kidney metabolism MDCK cells Kidney microcirculation Measurement technique Kidney rejection Mechanical strain 1067, 1431 Kidney rejection prediction elo Ege Ce I Pa EME rN > 2061 Kidney stones Medullary hypertonicity Kidney toxicity Membrane attack complex Kidney transplant Menopause Kidney transplantation 115, 1300, 1652, 1758 Mercuric chloride Kinetic modeling of Urea 76:S-28 Mesangial cell ROM a Sch uiahasie So -4)5 -2 aghe ainda s alee 76:S-3 Mesangial cell growth Knockout mice Mesangial cell vectors Korean PKDI Mesangial cells 400, 76:S-156 Mesangial deposits 966 Mesangial matrix eo Mesangiolysis 903 L Mesangium , 1912 Laser Doppler fluxmetry Mesothelial cell migration 1953 Left ventricular hypertrophy IWHCEAIING AGINONNS oo 5 5 ook ke Swe ee eee 748, 1267 Lesions Metabolic glomerular disease 1876 Leukocyte adhesion Metabolism 1016 Leukocytes Metalloproteinase 1841 Ligand Microalbuminuria , 1285 Linolenic acid PONE ro his S55 8:04 4.e set nde a elecle area aeean 137 Lipid peroxidation Microdissection 1346 Lipids q;-microglobulin Lipolysis B.-microglobulin Lipopolysaccharide Microvascular leakage Lipoxidation 425, 76:S-120 Middle molecule clearance Lt 2+ ya ace a eee gr arerarar rrr mer rare 2084 Millicell system Lithogenesis Mineral metabolism LLC-PK, cells Minimal change disease = L-NAME Mitogen-activated protein kinase 549, 691, 77:S-53 Long range polymerase chain reaction Mitogen-activated protein kinase phosphatase-1 27 Long-term graft survival Bravery cel se asaw & wiare ea cs a eee URE MONEE 65 ck dea os a eae Ss eee ele oe oe RSI CMRI sh 5 g's oi6 ias's $8 aainin esd doe eae alae 325 Molecule 1469 Losartan 2018 Monoclonal antibody Low birthweight 770 sp RE 182, 1135, 1603, 1920, PEGG TIGHE PRESSING. wok 6 ook cise eas sin cs wees 2147 EMO NINO oo oi0 S. 5.a a oa idcw 9 9.6 wid vera e anne eee Lupus nephritis 2215 Morality prediction Luteinizing hormone 569 260 Mortality WMI ee 5.54. 5) Siac oye iuc ir Seis weccmiee SoH 867, 1920 Mortality and hemodialysis Mortality and transplantation M Macrophage 100, 1664 Multi-organ failure Macrophage/monocyte 1492 Murine model Macrophages .............. 1055, 1186, 1469, 1941, 2166 Muscle wasting MaCTOPOTOUS TESINS . 2. 6... 6. kc ccs cde wen 76:S-60 Mutation Macula densa 740, 2075 Myofibroblast 2630 Key Word Index: Volume 58 N Osteopontin expression ...................2.-.2.4-3 7 et SE ok oh ih he:S iuas & spta iierdy SS, ital lo CRAs oles Se pera 2400 ADSEOODOTORIS: (5. s pes foie ss 2G Rs comalico uso e 4 ose c/s SOU Na*/H~™ exchange 12-O-tetradecanoyl phorbol 13-acetate Na,H exchanger Ovulatory disruption Nail-patella syndrome Oxalate PUMIREMEREIMIERS Tro) 5o02 hee cje ter cie<05 o's wad Sislo-s ase) 2 2 Oxidant stress NC1 domain Oxidation Necrosis hypertension Oxidative metabolism Necrotic damage Oxidative senescence and cell death Neonate blood Oxidative stress Nephrectomy Oxygen deprivation Nephrin Nephrogenesis P Nephrolithiasis Nephromegaly p27 and p57 Nephronophtisis p38 MAP kinase Nephropathia epidemica p38 Mitogen-activated protein kinase ............... 27 Nephropathic diabetes BAND MMRRL RN chs FPa nlar sors fci sso 6sa ise) geiosvac 8 ato enw 1d Voor 2061 Nephropathy 100, 740, Para-aminohippurate 1336 PNR UNNMNESMNEDERN S 2 ose 256s Sia ys yd Sin Kia: 99 8S 121952 Parathyroid 753 Nephrotic range proteinuria Parathyroid hormone 1023 Nephrotic syndrome 1238, 1973, Parathyroid hormone receptor 1440 Nephrotoxity . 1247, 1652, 2 Parenchymal ATGHNCCIUTE . 2... ee ee eb eee ens 2018 Neuronal nitric oxide synthase PARCHCONIANCEUS! ooo dh5 See Nae se eee sso sie ee we aS 2546 Neuronal NOS PCGIAUMICTITCA MIMCUIES o.oo cols see need eee eee 2138 Neutrophils Pentosidine Percutaneous biopsy Percutaneous transluminal angioplasty Nifedipine Peripheral blood mononuclear cells ............... 417 NIH Activity Index PETICOHEAMUIALYSALC 6 sss fea God sdie ow) oo dew eter Digs 2194 Nitrate Peritoneal dialysis . . 396, 400, 629, 1293, 1758, 2044, 76:S-47 123, 269, 881 Peritoneal dialysis fluids .....................2.5.1 8 PS HIMNEE MINAS Go i5)5 35.56 25 baa a Sanwa es 2075 Peritoneal exchange capacity Peritoneal injury Nondiabetic glomerulopathies Peritubular capillaries Non-enzymatic biochemistry 425 P-glycoprotein Nonenzymatic glycation 77:S-31, 77:S-40 Phosphate Noninsulin-dependent diabetes Phosphoprotein 1004 Noninvasive detection technique EAP UMNSIANS Gi5o )2 s) 60 ena ese Seald ad BELA SLD Gah SMES 2102 Noninvasive testing PRM PAE RINEE RLS 066. 2 65 sals isto ats: stash aca SSE Aa alae eR 1228 Nonphenacetin analgesics PEP eee e sk SiS oad Fistw a osha hiv wee ee ee 2492 PinS NisrNICNS RNRPRRIBEADNRDS 350.558 io 35 5.5 )5)6 < os sas' oS idos ose YS 1400 PDT ARG Ee BONES. 565.6 55566 islig 0 dao sien) & oleae ae 2599 Normalized protein catabolic rate 76:S-3 p27kip1 nPCR albumin 346 FUGSHIAMAOOSECEOMC 2 6.56)06.c sie eisis 0 sais als oes sie arscomee 2084 Nuclear factor-kB 1420, 77:S-19 Plasma filtration Nuclear protein binding Plasma osmolality Nucleotide sequences Plasma triglyceride Nutrition 1381, 2564 Plasmin Plasminogen activator inhibitor-1 O Plasmin/plasminogen activator system POSTIVE MODAN 3... 6 coe oc cen ics Sly ABI Platelet-derived growth factor 1,.25(OH)2D3 intact PTH 981 Podocytes CPUPINNCIPOIIES i eis ceceecnes 1885 Poly(ADP-ribose) polymerase Oncogenesis Polyclonal B cell activation Optical biosensor Polycystic kidney disease Optical hematocrit measurement Polycystin Organ donation POIVMENMBZROINOUUS 5 5.5.6 456-405. 8 aww ale cas wand eemnwes 1108 SMURF hoi sw 9hd io is in did wie ale bree ER 2585 Polymethylmethacrylate membranes eePOUT ETR”E TE ET ET TCC err e Polyol pathway Organ sharing Pore area test Organic anion transporter Post-transplant death AS e 539 as 5)a wb a4 Ae KR 1511 Post-transplant relapse RERUNI MR Spo 5 eat Oo acon tad tenella acailsi e eee ee 2502 Postnatal kidney development ................... 2291 SEMI eects io oleae So ot8 3.8 ikea Shore yee 396, 1788 Potassium citrate Osteopontin Potassium recycling Key Word Index: Volume 58 Predictive power of biopsy Renal artery stenosis Prednisolone Renal biopsy Prednisone POGUE SUOUONOIMD, nn. oo eee ecacvecucs 2492 Prenatal diagnosis Renal compression 721 Prepro-endothelin-1 mRNA BURR CENT 9222 51s 5s) ail asd Sie x taeA oe 2400 Prevalence Renal disease Primary hyperoxaluria type 1 Renal disease progression Primary vesicoureteric reflux Renal failure 400, 520, 1148, 1202, 1293, 1841, 2485 Re AI INOM RIS Psa Asa ara ol6 65 955d) thas: Suaiars: 9.4 0s a aleretald 283 Renal fibrosis 537 Programmed cell death 638, 2007 PURER MEMR NREERIQUNR 55.5: os. 6)a 's- o% ence0 6 nga tg ae Re 2053 Progression of renal disease ............... 293, 77:S-59 Renal gene 5 Progressive diabetic nephropathy LG 1. |a e ParmesanPy Progressive kidney disease ................... 513, 966 IGUAMNCHIOGVMAIINICS: o5 5 6 ois sacs cs dae cuseaacean 1336 PROstessive retial atrOpMy «2.le. ee .ese es 2301 Renal hypertrophy 162, 740 Progressive renal disease 90, 458, 770, 783, 959, 1088, Renal injury 658, 1219, 2592 1219, 1285, 1325, 1381, 1719, 1885, 2425 FRCHae IISUCICNOY ooo esc cieetencwneasseees 569, 629 Progressive renal failure 1413 Renal interstitium Progressive renal injury 1742 Renal K and Na Progressive renal lesions 184] Renal mass reduction Progressive tissue fibrosis ...............-++++4++ 2028 Renal mesenchyme IEETee Ter e ee 647 Renal microcirculation Proliferation , 1980 Renal osteodystrophy iee cha err Renal pelvis EMU RERRESE CPS os oa) Gio ala p5 .4,a e Ge. ¥1G0) we aero 2420 Renal physiology Protem energy malnutrition .............006.5+.+25he Renal protective agents PROLESCR OENCEREREN Ms, 8 2250 5:50a i-e aiken abioco.o vevener eel ona lle e Renal protein uptake Protein glycation Renal proximal tubule damage Protein kinase A 2 Renal proximal tubules Protein kinase C 691, 1431, 77:S-19, 77:S-26, 77:S-4( Renal replacement fluid Reet eet AMIN OR 2.6 6 ka id 5 Sis l'vw noun ae ee dew Uae were ene 2069 Renal replacement therapy 867, 1318, 76:S-72, 76:S-148 Protein metabolism 1, 2564 Renal scarring 354, 2377 RUPEE SENCECRUIOM 3 55S nla dake ace eee ie hme 2485 Renal stone formers 1278 Proteinuria 100, 131, 144, 302, 520, 537, 618, 1098, Renal stones 748 1135, 1247, 1342, 1461, 1797, 1973, 2111, 2502, 77:S-104 IRGiIah StQies TH NEONAIES =<... ok 6 cies cee dae oes ee 2102 Proteinuria in utero 972 Renal toxicity 33, 2259 RR RSOC NOAM xclca 016.55. oo. 3:s sa:a ia si ea jarwrare e418 '0.6 oie ale OL Renal transplantation 491 Proximal renal tubule 162 Renal tubular obstruction . 2301 Proximal tubule Renal tubules 1511 Ptgs2 gene Renal vasculature 1588 Purinoceptors Renin 219, 2420 Puromycin aminonucleoside Renin system 153 Pyridoxal-5’'-phosphate Renin-angiotensin system 2320 Renoprotection 618 Q Reperfusion injury 838 10q26 monosomy Replication-deficient recombinant adenovirus 1500 Residual renal function 446 Retinopathy 302 Ribonuclease protection assay .. 1481 Risk factors Radial bone density Risk factors for ESRD Radiation exposure Risk for IgAN RNA preservation Ramipril 53, 1469 RNase protection assay Reactive carbonyl compound .................... 2518 Reactive oxygen species S Receptor agonists 3 SRR cec ota oad. 66 hin casio’a it unce au SS) Selo ee 76:S-72 Receptor binding 1902 Salt dependency RECEP SUORVIES sc chee cscs ces ces wee eae SNe eEI N MIRINNIC.53,5. 5's.4 .4 19)w is gal aig andi ara SOT 2462 Receptors 1931 UNRATE se oro.9 55.« .4i5) aloe 00.5) 4p eresp lacename Recombinant human activin A 1511 Salt-sensitive hypertension ....... 6.6 cece scccussees 2007 Recombinant human growth hormone ............. 2564 Sarcoplasmic reticulum Recombinant proteins 1580 Scarring 1088, 1186 Sr eareremrerererscs | 7. Scatter factor Remnant kidney model Scleroderma Renal ammonia SOGH RN CURRAN bi o.5.5 55) 6:59 Crelgrey inten eaten 1160 2632 Key Word Index: Volume 58 Sclerosis Thai PKDI Scoring systems Thapsigargin Secondary hyperparathyroidism Thiazide Selectivity index Thiazide diuretic Sepsis MRE eR oo 5s. aude wis ae tk we FO 2341 Serial hemodialysis analysis Thick ascending limb Serum albumin Thin limb of Henle Serum total cholesterol Severity of illness index THP-1 cells Sib-pair linkage analysis Thrombocytopenic purpura Sieving coefficient Thrombosis Signal transduction 898, 77:S-45 Thy 1.1 glomerulonephritis EE ee Se eee 269, 1431, 77:S-53 Tissue core sample Single nucleotide polymorphism Tissue inhibitor of metalloproteinase Skeletal deformities in children Tissue inhibitors Skin microcirculation Tissue repair SR MRR Na Goi s9 oa 5)a isgd, 66S Sid S10 Kok Basle 2186 Co, Se ee ree 1285 Slit diaphragm 972, 1461 Total body nitrogen 77:S-45, 77:S-76 Total body water Smad proteins Total-body irradiation Small vessel vasculitis Toxic COX-2 blockade Smoking Toxicity a-Smooth muscle actin .............. 51,587, 598, 1186 TPA Transactivation Sodium absorption Transcription Sodium citrate Transcription factor binding site Transcription factors Sodium handling Transfection SUNN TT OMIM PRRMESES 3) ose) caieirave sd:a arctan ad wie SEL Sodium kinetic modeling Transferrin Transforming growth factor 77:S-13, 77:S-45 Sodium retention Sodium-chloride cotransporter Transforming growth factor-B 1389, 1492, 1588, 1664, 1963, 77:S-40, 77:S-81 Sodium/dicarboxylate cotransport Transforming growth factor-B1 Sodium/hydrogen exchanger 229, 1623, 2069 Sodium/lithium countertransport 229 Transforming growth factor-B2 Soluble ICAM Transforming growth factor-B superfamily Solute clearance Transgenesis 77:S-3 Solute transport Transgenic mice 1055, 1580 Transmembrane pressure Sorbent Transmembrane proteins .................00000- 2331 Sorbents TYAMSPlANO PIOSTAM: «so... 06.6 ee os kee oes os RIOD Spironolactone Transplant rejection Squamous cell carcinomas oy ayy IS SPS alin ee ee ew 1420 Transplantation , 2533, 2546 Triglycerides Sterility Steroid therapy Trimetazide TRI RAIS oo os, pss s Sob soi oe bile a eke mes Store-operated calcium entry Tubular cell apoptosis Streptozotocin 740, 1677, 2320 Tubular dysfunction ROI NSRS Se P 56 0s oata tg d Ss aia 4 40'S) 9 2 Die eee & Se Tubular epithelium Stress-activated protein kinase Tubular lesions PRUANU MMCPD OIODOCLEOI Y 5 5.55 os 6 5 ose dscns’ bo ae DEEDS Tubular reabsorption Survival Tubulitis Synthetic murine leptin 989 Tubulointerstitial damage 137, 1135 LO io DOU) aa nr Perera tT 1765 Tubulointerstitial fibrosis .................00005. 1797 Systemic autoimmune disease ................... 2473 Tubulointerstitial hypertrophy Systemic hypertension Tubulointerstitial injury 1469, 1569 Systemic lupus erythematosus TGRURIISTRIINIR THCPNTINS ww eee ceess 1603 Systemic lupus nephritis Tubulointerstitium 1557, 1641 Systolic blood pressure ................... 2093, 2147 Tumor malignancy 647 Tumor necrosis factor T Tumor necrosis factor-a Tunneled catheter T cell receptor CWO RROD MERORED ger5 50665 So aihesip avg. Seb eae 2138 T lymphocyte Two-step sorbent system Tenckhoff curled catheter L-type channels Testis Type 2 diabetes mellitus Type IV collagen